Correspondence on the USPSTF “D” recommendation

By Members of Congress, Roundtable Organizations, Heads of Federal Agencies, and Others

Click on the links below to view correspondence by members of Congress, the Prostate Cancer Roundtable, and other organizations, and agency responses to that correspondence:

Rep. Runyan and Congressional Men’s Health Caucus press release, May 2012
Rep. Christensen press release, May 2012
Sec. Sebelius response to Rep. Baca, Feb. 2012
Sec. Sebelius response to Rep. Price, Feb. 2012
Sec. Sebelius response to Rep. Runyan, Feb. 2012
The New Jersey legislature passed a resolution opposing the USPSTF “D” Recommendation, Jan. 2012
Reps. Kucinich and Burton letter to HHS Sec. Sebelius, Nov. 2011
Sec. Sebelius response to Reps. Kucinich and Burton, Dec. 2011
Rep. Kucinich press release, Jan. 2012.
Rep. Price “Dear Colleague”, Nov. 2011
Rep. Barrow letter to HHS Sec. Sebelius, Nov. 2011
Rep. Christensen letter to HHS Sec. Sebelius, Nov. 2011
Reps. Towns, Meeks, and Cummings letter to HHS. Sec. Sebelius, Nov. 2011
Letter to Chairwoman Virginia Moyer, Chair of the USPSTF, from the American Association of Clinical Urologists (AACU), Nov. 2011

Prostate Cancer Roundtable Correspondence

Letter to HHS Secretary Sebelius, March 2012
A letter requesting that the USPSTF PSA recommendation process be reopened was sent to Secretary Sebelius on March 22, 2012 by ten members of the Prostate Cancer Roundtable. The letter references the encouraging news from the ERSCP study, showing a reduction in prostate cancer-specific mortality of 29% at 11 years. A previous letter to Dr. Collins asking for an embargo on use of the data from the prostate arm of the PLCO study was enclosed. The letter to Sec. Sebelius can be found here.

Letter to Dr. Francis Collins, Director of the National Institutes of Health, Jan. 2012
Ten members of the Prostate Cancer Roundtable sent a letter to Dr. Francis Collins in January 2012 asking that he initiate a quality review of the data used in the prostate arm of the ongoing Prostate, Lung, Colorectal, and Ovarian (PLCO) study.  The group also requested that he embargo use of the study for any policy initiatives until the review is complete.  That letter can be found here.

Letter to HHS Secretary Sebelius and AHRQ Director Clancy, Dec. 2011
The Prostate Cancer Roundtable in December 2011 sent the coalition’s comments and a cover letter to HHS Sec. Sebelius with a copy to AHRQ Director Clancy.  See the letter and comments here.

Letter from AHRQ Director Clancy to Prostate Cancer Roundtable, May 2012
AHRQ Director Clancy responded to the Prostate Cancer Roundtable’s concerns about the quality of evidence reviewed in the USPSTF’s final prostate cancer screening recommendation. Read the letter here.

Letter from AHRQ Director Clancy to Prostate Cancer Roundtable, Jan. 2012
AHRQ Director Clancy responded to the Prostate Cancer Roundtable letter and comments.  She sent a letter to the Roundtable and an identical letter to each individual organization member.  The letter sent to WAPC is found here.

Prostate Cancer Roundtable Organization Comments.

Click on the links below to view comments submitted to the USPSTF by Prostate Cancer Roundtable Member Organizations.

Malecare
Men’s Health Network (supplemental comments)
Men’s Health Network (original comments)
Men’s Health Network (Statement to Secretary Sebelius)
National Alliance of Prostate Cancer Coalitions
Prostate Cancer Foundation
Prostate Health Education Network
UsToo
Women Against Prostate Cancer
ZERO – The Project to End Prostate Cancer